CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancer. [electronic resource]
Producer: 20131017Description: 12325-30 p. digitalISSN:- 1091-6490
- Animals
- Antibodies, Monoclonal -- immunology
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents -- administration & dosage
- Apoptosis
- Carcinoma, Pancreatic Ductal -- drug therapy
- Connective Tissue Growth Factor -- antagonists & inhibitors
- Deoxycytidine -- administration & dosage
- Liver Neoplasms -- secondary
- Mice
- Pancreatic Neoplasms -- drug therapy
- Survival Analysis
- X-Linked Inhibitor of Apoptosis Protein -- metabolism
- Gemcitabine
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.